Delivering CAR‐T cells into solid tumors via hydrogels
Abstract Chimeric antigen receptor (CAR)‐T cell therapy is a promising form of cancer immunotherapy that genetically modifies a patient's own T cells to express CARs for the specific recognition and eradication of cancer cells. Unfortunately, unlike the impressive advancements it achieves in he...
| Published in: | MedComm – Oncology |
|---|---|
| Main Authors: | , , , |
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-06-01
|
| Subjects: | |
| Online Access: | https://doi.org/10.1002/mog2.40 |